| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |